Table 2.

Incidence of adverse events per patient

	All Patients (N = 30)
Patients with any treatment-emergent AE, n (%)	30 (100)
Patients with any treatment-emergent serious AE, n (%)	12 (40)
Patients with a grade 3 treatment-related AE, n (%)	0
Patients with a grade 4 treatment-related AE, n (%)	0
Patients with a grade 5 treatment-related AE, n (%)	1 (3)
Incidence of treatment-related AEs, n (%)	18 (60)
Fatigue, all grades	4 (13)
Grade 1	3 (10)
Grade 2	1 (3)
Infusion-related reaction, all grades	2 (7)
Grade 1	2 (7)
Pyrexia, all grades	2 (7)
Grade 1	2 (7)
Decreased appetite, all grades	2 (7)
Grade 1	2 (7)
Hypophosphataemia, all grades	2 (7)
Grade 2	2 (7)

AE adverse event

*AEs occurring in in ≥5% of patients are shown